Schedule 13G ownership disclosure

Tvardi Therapeutics Inc

Common stock, par value $0.001 per share · CUSIP: 140755307

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Slate Path Capital LP

    Shares: 704,118.00 · Class: 7.5%

  • David Greenspan

    Shares: 704,118.00 · Class: 7.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003656
Form type
SCHEDULE 13G
Filer
Slate Path Capital LP
CIK
CIK 1559706
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub